跳至主要内容
临床试验/CTRI/2020/05/025454
CTRI/2020/05/025454尚未招募未知

Magnesium supplementation in migraine prophylaxis

Vinayaka missions medical college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosis with migraine according to ICHD criteria
  • Migraine group in the attack free period

排除标准

  • 1.Contraindication to magnesium therapy (e.g. renal failure, nephrolithiasis)
  • 2.Pregnancy or planned pregnancy
  • 3.Breast feeding women
  • 4.Menstrual migraine
  • 5.Nonmigraine headache
  • 6.Dependence or abuse of drugs
  • 7.Psychiatric or chronic systemic illness
  • 8.Foreseeablee poor compliance
  • 9.Intake of antidepressants, neuroleptics, minor or major tranquillizers, drugs used for the treatment of affective disorders (e.g. lithium, carbamazepine)
  • 10.Headache prophylaxis (e.g. beta receptor blockers, calcium antagonists) within last 3 months

研究者

发起方
Vinayaka missions medical college and hospital

相似试验